Literature DB >> 7540904

CD40 and its ligand: central players in B lymphocyte survival, growth, and differentiation.

J Gordon1.   

Abstract

This article brings together information garnered over the last 10 years on the B cell-associated CD40 surface glycoprotein. The discovery in 1992 of a natural counterstructure, the CD40 ligand (CD40L), which can be rapidly induced on T-cells has hastened research and increased interest in this area dramatically. It has become clear that CD40 and its ligand are central players in B cell responses to T-dependent antigens. The capacity of CD40 to deliver signals for B cell growth, differentiation and survival is covered together with discussion of the signal transduction pathways which operate to bring about these changes. Future issues surrounding this important receptor-ligand pair are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540904     DOI: 10.1016/0268-960x(95)90040-3

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  12 in total

Review 1.  Fortifying B cells with CD154: an engaging tale of many hues.

Authors:  J Gordon; J D Pound
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

Review 2.  Life and death within germinal centres: a double-edged sword.

Authors:  Liliana Guzman-Rojas; Jennifer C Sims-Mourtada; Roberto Rangel; Hector Martinez-Valdez
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

3.  Functional activity of CD40 antibodies correlates to the position of binding relative to CD154.

Authors:  T A Barr; A W Heath
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

4.  Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation.

Authors:  Jalal Ahmed-Choudhury; Clare L Russell; Satinder Randhawa; Lawrence S Young; David H Adams; Simon C Afford; Jalal Ahmed Choudhury
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

5.  Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step.

Authors:  D E Macfarlane; L Manzel; A M Krieg
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

6.  CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily.

Authors:  A G Eliopoulos; C Davies; P G Knox; N J Gallagher; S C Afford; D H Adams; L S Young
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.

Authors:  A G Eliopoulos; S M Blake; J E Floettmann; M Rowe; L S Young
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Defective integration of activating signals derived from the T cell receptor (TCR) and costimulatory molecules in both CD4+ and CD8+ T lymphocytes of common variable immunodeficiency (CVID) patients.

Authors:  V Thon; H M Wolf; M Sasgary; J Litzman; A Samstag; I Hauber; J Lokaj; M M Eibl
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

Review 9.  Toll-like receptors in mediating pathogenesis in systemic sclerosis.

Authors:  L Frasca; R Lande
Journal:  Clin Exp Immunol       Date:  2020-02-21       Impact factor: 4.330

10.  Hypereosinophilia presenting as eosinophilic vasculitis and multiple peripheral artery occlusions without organ involvement.

Authors:  Sung-Hwan Kim; Tae-Bum Kim; Young-Sun Yun; Jung-Im Shin; Il-Young Oh; Jung-Ju Sir; Kyung-Mook Kim; Hye-Kyung Park; Hye-Ryun Kang; Yoon-Seok Chang; Yoon-Keun Kim; Sang-Heon Cho; Yeong-Wook Song; Dong-Chul Choi; Kyung-Up Min; You-Young Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.